GUARDIAN WEALTH ADVISORS, LLC / NC
Position in EPRX — Eupraxia Pharmaceuticals Inc.
CIK 1901403
RALEIGH, NC
Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,020
+$520 QoQ
Shares Held
10,500
+5.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#46
of 54 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GUARDIAN WEALTH ADVISORS, LLC / NC holds $1,614,041 across 6 Biotechnology names. EPRX ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,053 | $470,206 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
443 | $342,279 | |
| 3 | MIST |
Milestone Pharmaceuticals Inc.
|
280,250 | $333,497 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
7,950 | $220,215 | |
| 5 | PGEN |
Precigen, Inc.
|
44,399 | $171,824 | |
| 6 | EPRX |
Eupraxia Pharmaceuticals Inc.
This page
|
10,500 | $76,020 |
All Filings in EPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,020 | 10,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,500 | 10,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||